Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
Balancing single-asset interest with portfolio goals
Neil explains handling investors who want single assets while maintaining BridgeBio's broader mission and scaling intent.
Play episode from 28:47
Transcript
